The disquieting patterns of end-of-life care
in the United States have been well documented. In the last month of life, one
in two Medicare beneficiaries visits an emergency department, one in three is
admitted to an intensive care unit, and one in five has inpatient surgery. But
one of the most sobering facts is that no current policy or practice designed
to improve care for millions of dying Americans is backed by a fraction of the
evidence that the Food and Drug Administration would require to approve even a
relatively innocuous drug.
See:
Toward Evidence-Based End-of-Life Care
Scott D. Halpern, M.D., Ph.D. N Engl J Med 2015; 373:2001-2003
Free Full Text Online.
No comments:
Post a Comment